title: [Orthostatic hypotension in the elderly].
abstract: Orthostatic hypotension (OH) is defined as a decrease in systolic blood pressure of 20 mmHg, or a decrease in diastolic blood pressure of 10 mmHg within three minutes of standing. It results from an inadequate response to postural changes in blood pressure. Common symptoms include dizziness, light-headedness, blurred vision, weakness, fatigue, nausea, palpitations, sweating, head and neck ache, slow cognitive performance and transient loss of conscientiousness. OH is a common problem among elderly patients and its aetiology is diverse, including autonomic nervous system dysfunction, cardiac problems, medication side effects, ageing changes or transitory deregulation of blood volume. The instrumental diagnosis can be easily accomplished by the tilt-table test, with continuous monitoring of blood pressure and cardiac parameters. It is a non-invasive technique and needs minimal collaboration from the patient. In our experience, when reviewing 327 patients, aged over 40 years and examined because of clinical suspicion of OH, the prevalence thereof was 51% whereas if focused in subjects older than 70, OH was proven in 90% of the cases. The older the patients, the more frequently they presented general deterioration, neurological or cardiac problems as well as pharmacological side effects. Ruling out neurological or cardiac malfunction can drastically improve the prognosis with possible reversibility of symptoms. Some nonpharmacological and pharmacological approaches to improve management of OH and life quality are described for guidance.
authors.affiliation: Sección de Sistema Nervioso Autónomo. Servicio de Neurofisiología Clínica, Hospital Universitario La Paz, 28046 Madrid, Espana. mteresa.ferrer@salud.madrid.org
authors.forename: Teresa
authors.initials: T
authors.lastname: Ferrer-Gila
authors.forename: Cristian
authors.initials: C
authors.lastname: Rízea
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D001342:Autonomic Nervous System Diseases / Q000150:complications / Q000175:diagnosis; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003681:Dehydration / Q000150:complications / Q000628:therapy; D003943:Diagnostic Techniques, Neurological; D005438:Fludrocortisone / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D008659:Metabolic Diseases / Q000150:complications / Q000175:diagnosis; D008875:Middle Aged; D053828:Stockings, Compression; D013566:Sympathomimetics / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
chemical_list: D000697:Central Nervous System Stimulants; D013566:Sympathomimetics; D014667:Vasopressins; D005438:Fludrocortisone